Kamyar Kalantar-Zadeh M.D. to Metformin
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Metformin.
Connection Strength
4.531
-
Metformin in chronic kidney disease: a strong dose of caution. Kidney Int. 2020 11; 98(5):1101-1105.
Score: 0.673
-
Further clarifying the relationship between metformin, acute kidney injury and lactic acidosis. Nat Rev Nephrol. 2017 12 13; 14(1):70.
Score: 0.551
-
Diabetes mellitus: Complex interplay between metformin, AKI and lactic acidosis. Nat Rev Nephrol. 2017 09; 13(9):521-522.
Score: 0.537
-
Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data. Nephron. 2017; 135(2):147-153.
Score: 0.509
-
Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety! Diabetes Care. 2016 Jul; 39(7):1281-6.
Score: 0.498
-
Restricting Metformin in CKD: Continued Caution Warranted. Am J Kidney Dis. 2015 Dec; 66(6):1101-2.
Score: 0.479
-
Metformin in chronic kidney disease: more harm than help? Lancet Diabetes Endocrinol. 2015 Aug; 3(8):579-81.
Score: 0.464
-
Case 23-2013: a 54-year-old woman with metformin toxicity. N Engl J Med. 2013 10 31; 369(18):1769.
Score: 0.414
-
Case records of the Massachusetts General Hospital. Case 23-2013. A 54-year-old woman with abdominal pain, vomiting, and confusion. N Engl J Med. 2013 Jul 25; 369(4):374-82.
Score: 0.406